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Abstract
Background: Borrelia burgdorferi (sensu lato), the causative agent of Lyme borreliosis is a bacterium transmitted by
hard ticks, Ixodes spp. Bacteria are injected into the host skin during the tick blood meal with tick saliva. There,
Borrelia and saliva interact together with skin cells such as keratinocytes, fibroblasts, mast cells and other specific
immune cells before disseminating to target organs.
Methods: To study the role of mast cells in the transmission of Lyme borreliosis, we isolated mouse primary mast cells
from bone marrow and incubated them in the presence of Borrelia burgdorferi (sensu stricto) and tick salivary gland
extract. We further analyzed their potential role in vivo, in a mouse model of deficient in mast cells (Kitwsh−/− mice).
Results: To our knowledge, we report here for the first time the bacteria ability to induce the inflammatory response
of mouse primary mast cells. We show that OspC, a major surface lipoprotein involved in the early transmission of
Borrelia, induces the degranulation of primary mast cells but has a limited effect on the overall inflammatory response
of these cells. In contrast, whole bacteria have an opposite effect. We also show that mast cell activation is significantly
inhibited by tick salivary gland extract. Finally, we demonstrate that mast cells are likely not the only host cells involved
in the early transmission and dissemination of Borrelia since the use of mast cell deficient Kitwsh−/− mice shows a
limited impact on these two processes in the context of this mouse genetic background.
Conclusions: The absence of mast cells did not change the replication rate of Borrelia in the skin. However, in the
absence of mast cells, Borrelia dissemination to the joints was faster. Mast cells do not control skin bacterial
proliferation during primary infection and the establishment of the primary infection, as shown in the C57BL/6
mouse model studied. Nevertheless, the Borrelia induced cytotokine modulation on mast cells might be involved
in long term and/or repeated infections and protect from Lyme borreliosis due to the development of a
hypersensitivity to tick saliva.
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Background
Ixodes ticks are vectors of several pathogens including
viruses (e.g. tick-borne encephalitatis virus), parasites
(e.g. Babesia) and bacteria (e.g. Borrelia) [1]. They are
transmitted to the host during the tick blood meal which
lasts several days. Pathogens are inoculated into the skin
with tick saliva. In the case of Lyme borreliosis, caused
by B. burgdorferi (sensu lato) [2], bacteria first multiply
in the skin before disseminating to target organs (heart,
distant skin, joints) [3]. However, part of them persist
for several weeks in the skin after transmission [4]. Skin
cells, including keratinocytes, fibroblasts, endothelial
cells, dendritic/Langerhans cells, T cells and mast cells
(MCs), are those of immune importance since they are
likely to be the first cells encountered by the bacteria
[5]. Most of these cell functions have been shown to be
inhibited by tick saliva compounds such as sialostatin L
and Salp15 during bacteria transmission by I. scapularis
ticks [6–12]. Notably, Salp15 protects B. burgdorferi (s.l.)
from the host immune system by binding to the bacteria
surface lipoprotein OspC [13]. OspC is a major Borrelia
surface lipoprotein upregulated during the early trans-
mission from the tick to the vertebrate host [14]. More-
over, Salp15 targets immune cells such as dendritic cells
and T cells by inhibiting cytokine expression and cell
maturation [15, 16]. The tick saliva also inhibits other
mechanisms such as hemostasis, pain and itch to in-
crease tick blood meal efficiency [17]. Pathogens have
evolved to use these saliva-associated inhibition mecha-
nisms to increase their transmission rate [11].
MCs are widely distributed throughout the body with
specific locations at the surface epithelia such as the
skin, the lung and gastrointestinal and genitourinary
tracts [18]. These cells are well known for their associ-
ation with pathological conditions such as asthma, al-
lergy or anaphylaxis. MCs are increasingly studied with
new evidence of their involvement in parasitic, bacterial
and viral infections. They can directly sense Pathogen-
Associated Molecular Patterns (PAMPs) through Pattern
Recognition Receptors (PRRs) such as Toll Like Recep-
tors (TLRs) [19]. They also can detect antigens through
the binding of antibodies to their Fc receptors. MC re-
sponse to pathogens depends on the PAMPs: some
PAMPs induce only cytokine expression (TNF-α, IL-6,
IL-13, IL-1β, IL-4, IL-5, IFN-γ) while others induce cyto-
kine production as well as degranulation, a mechanism
inducing preformed inflammatory mediator release [20].
In case of bacterial pathogenesis, the release of TNF-α,
histamine or vascular endothelial growth factor (VEGF)
by MCs increase vascular permeability. Chemokines pro-
duced by MCs increase the inflammatory cell attraction
at the infection sites (eosinophils, neutrophils, NK cells)
[21]. MCs can also directly kill pathogens through anti-
microbial peptides such as cathelicidins [22]. Moreover,
their ability to present antigen and to secrete inflamma-
tory mediators allows the recruitment of dendritic cells
as well as T cells at the infection site. All these processes
give them a central role between innate and adaptive im-
munity [23, 24].
MCs have been poorly studied in the context of Lyme
borreliosis. Currently, it is known that murine MC lines
respond to Borrelia by secreting TNF-α and by slowly
degranulating. This activity seems to depend in part on
surface proteins but not on the lipoprotein OspA [25].
Fc receptors seem to be involved through an antibody-
independent mechanism [26]. However, MC lines are
not fully mature cells compared to bone marrow derived
primary mast cells. In this study, for the first time we
analyzed primary MCs response to B. burgdorferi (sensu
stricto) and its lipoprotein OspC, a lipoprotein essential
for the early bacterial transmission from the tick to the
vertebrate host [27, 28]. We also explored in vitro the
tick saliva impact on MCs response to Borrelia. Finally,
we used a murine MC deficient model to study their
involvement in the in vivo infection process.
Methods
Borrelia
Borrelia burgdorferi (s.s.) strain 297 was cultured in
BSK-H medium (Sigma-Aldrich, St. Quentin Fallavier,
France) at 33 °C, used at passage 8 in the late-log-phase,
centrifuged, and then washed twice (30 min, 5000×g)
with cell culture media. Borrelia burgdorferi (s.s.) 297,
OspC-deficient and complemented mutants, have been
described previously [14].
Mast cell culture
Primary MCs were generated by extracting bone marrow
cells from the femurs of 4 to 8 week-old C57BL/6 mice
and culturing the cells at 37 °C, 5% CO2 in RPMI 1640
(Life Technologies, Villebon sur Yvette, France) supple-
mented with 10% inactivated FBS (Life Technologies),
glutamine, non-essential amino acid (NEAA), penicillin/
streptomycin, and 2-mercaptoethanol. Recombinant mur-
ine IL-3 (1 ng/ml; R&D Systems, Lille, France) and recom-
binant murine stem cell factor (SCF) (20 ng/ml; R&D
Systems) were used in vitro for differentiation of the MC
precursor [29]. Medium was changed twice a week. After
4 weeks, MC maturation and purity were confirmed by
the expression of CD117 and FcεRI measured by flow cy-
tometry and by metachromatic staining with toluidine
blue. The purity of MCs was greater than 85% (Additional
file 1: Figure S1).
Mast cell degranulation and activation
Degranulation was assessed by measuring the activity of
β-hexosaminidase [30–32] in the supernatants of 1 × 105
MCs in 200 μl Tyrode’s buffer (0.1% bovine serum
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albumin, 0.1% glucose, 2 mmol/l MgCl2, 137.5 mmol/l
NaCl, 12 mmol/L NaHCO3, 2.6 mmol/l KCl, pH 7.4) in-
cubated for 2 h at 37 °C with different concentrations of
B. burgdorferi (s.s.) (MOI 50:1 or 100:1), L-OspC (10 or
50 ng/ml), unlipidated-OspC (10 or 50 ng/ml) and/or
saliva (20 μg/ml). For each sample assayed, supernatant
aliquots (20 μl) were mixed with substrate solution
(100 μl), which consisted of 1 mM 4-methylumbelliferyl-
2-acetamide-2-deoxy-β-D-glucopyranoside (Calbiochem,
Fontenay sous Bois, France) in 0.1 M sodium citrate
buffer (pH 4.5), and were incubated for 2 h at 37 °C.
The reaction was then stopped by the addition of 12 μl
of 0.2 M glycine (pH 10.7). The reaction mixtures were
excited at 365 nm and measured at 460 nm in a fluores-
cence plate reader (Gemini EM microplate spectrofluo-
rometer, Molecular Devices). To determine the total
cellular content of this enzyme, an equivalent number of
cells were lysed with 1% triton X-100 (Sigma-Aldrich)
and the plate blank was deducted. Release of β-
hexosaminidase was calculated as the percentage of the
total enzyme content.
Inflammatory response was assessed by incubating MCs
with different concentrations of B. burgdorferi (s.s.) (MOI
50:1 or 100:1), L-OspC (10 or 50 ng/ml), unlipidated-
OspC (10 or 50 ng/ml) and/or SGE (20 μg/ml) for 6 or
24 h at 37 °C. Cells and supernatants were collected and
separated by centrifugation (300 g, 10 min).
Tick salivary glands
SGE was obtained after dissection of female ticks fed for
three days, and used at 20 μg/ml as described previously
[7]. SGE was tested by the Limulus assay to check for
the presence of endotoxins and was found to contain
< 0.3 endotoxin units.
Mice and bacterial challenge
MC-deficient (KitWsh−/−) mice were kindly provided by
Dr. Mécheri (Pasteur Institute, Paris, France). KitWsh−/−
and C57BL/6 mice were bred at the animal facilities of
the institute of bacteriology (University of Strasbourg,
France) according to regulations of the CREMEAS.
Borrelia (103/100 μl) were intradermally injected into
the dorsal thoracic area of mice. With a biopsy punch
(Stiefel laboratory), 3 mm skin biopsies were then col-
lected at 3, 5, 7 and 15 days after the inoculation for
Borrelia quantification by quantitative PCR (qPCR).
Quantification targeting the flab gene was performed as
described previously [33]. Numbers of Borrelia in the
skin were normalized to 104 GAPDH DNA copies. Or-
gans were collected at different time points post infec-
tion to check for the presence of spirochetes, either by
culture in BSK-H medium and observation under dark
field microscopy (heart, joint) or by PCR (ear tissue).
ELISA
To measure IL-6 secreted by MC, enzyme-linked im-
munosorbent assays (ELISAs) were performed on cell
supernatants. Protocols were based on sandwich tech-
niques, as described by the manufacturer (R&D systems,
Lille, France).
Flow cytometry
MCs were centrifuged at 800× g for 15 min at room
temperature. Cells (5.105 cells/ml) were resuspended in
PBS-EDTA 3 mM. Fc receptors were blocked with Fc
blocking reagent (CD16/CD32) for 5 min. Cells were fi-
nally processed for staining with PE-labeled rat anti-
mouse CD 117 (eBioscience, Fontenay sous Bois, France),
(1/300) and APC-labeled american hamster anti-mouse
FcεRI (eBioscience, 1/300) in PBS-EDTA 3 mM before
analysis with a FACScalibur (BD Biosciences, Le Pont de
Claix, France) equipped with Flowjo software.
Real-time quantitative RT-PCR
Quick-RNA MiniPrep (Zymo Research, St Quentin En
Yvelines, France) was used to isolate total RNA. One
microgram of total RNA for cDNA synthesis by the
iScript cDNA Synthesis Kit (Bio-Rad, Marnes la Co-
quette, France) was used; it was amplified by real-time
RT-PCR in an ABI 7300 Real-Time PCR system (Applied
Biosystems, Illkirch, France). The amplification cycle
consisted of initial denaturation at 95 °C for 10 min
followed by 45 cycles each at 95 °C for 10 s and 60 °C
for 1 min and a final melt curve analysis: 55 °C for 30 s
with an increase of 0.5 °C/cycle to 95 °C. Primers, probes
and RNA analysis reagents (TaqMan Master Mix re-
agents kit) used for real-time RT-PCR were obtained
from Applied Biosystems (Illkirch, France). We used the
comparative ΔΔCT method to determine the quantifica-
tion of gene expression, normalized the target gene (IL-
6, F: 5′-TAG TCC TTC CTA CCC CAA TTT CC-3′
and R: 5′-TTG GTC CTT AGC CAC TCC TTC-3′;
MCP-1, F: 5′-CTT CTG GGC CTG CTG TTC-3′ and
R: 5′-CCA GCC TAC TCA TTG GGA TCA-3′; FlaB, F:
5′-TTT CAG GGT CTC AAG CGT CCT G-3′ and R:
5′-GCA GGT GCT GGC TGT TGA GC-3′) expression
in the test samples to the endogenous reference GAPDH
(F: 5′-CCA ACC GCG AGA AGA TGA CC-3′ and R:
5′-GAT CTT CAT GAG GTA GTC AGT-3′) level and
reported them as the fold difference relative to GAPDH
gene expression in untreated baseline control. We
performed all the assays in triplicate and repeated the
experiments at least three times.
Statistical analyses
Each experiment was carried out at least three times in
independent experiments. The most representative ex-
periment is shown. Results represent the mean ± standard
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deviation (SD) of at least triplicates of one experiment
and were analyzed by two-tailed Student’s t-test or
ANOVA with Tukey post-hoc test using GraphPad soft-
ware. Differences in values were considered significant if
P < 0.05 (*P < 0.05; **P < 0.01; ***P < 0.001). For in vivo
studies, a minimum of 5 mice has been used at each
time point of the kinetics to get significant results.
Results
Borrelia burgdorferi (s.s.) 297 and its lipoprotein L-OspC
differently activate mast cells
Primary MCs generated by culturing mice bone marrow
cells for 4 weeks with IL-3/SCF were used. To study the
impact of Borrelia on MC activation, primary MCs were in-
cubated with different concentrations of B. burgdorferi (s.s.)
297 or its surface lipoprotein OspC (Fig. 1). Degranulation
was only induced by L-OspC, not by whole B. burgdorferi
(s.s.) 297 (Fig. 1a) or by unlipidated OspC protein (data not
shown). However, both L-OspC and Borrelia induced pro-
inflammatory cytokine and chemokine expression by MC
at protein (IL-6) and mRNA (IL-6 and MCP-1) levels (Fig.
1b-d). Cathelicidin, an antimicrobial peptide well-known to
be produced by MCs [22], was poorly or not induced in
our experiment (data not shown).
L-OspC is not essential for murine mast cell activation by
Borrelia
OspC is an essential lipoprotein for the transmission of
Borrelia from the tick to the vertebrate host [27, 28].
However, to determine whether L-OspC is essential for
MC activation in vitro in the context of the whole
bacteria, we activated primary MC with an OspC-KO
mutant strain of B. burgdorferi (s.s.) 297 (Fig. 2). We
show here that IL-6 protein secretion as well as IL-6 and
MCP-1 mRNA expression were similarly induced by
wild type, mutant and the complemented strains.
Mast cell inflammatory response against Borrelia is
inhibited in part by tick saliva
Since B. burgdorferi (s.s.) 297 transmission occurs in the
presence of tick saliva, we explored its effect on the MC
inflammatory response in vitro (Fig. 3). Tick salivary gland
extract (SGE) was incubated with primary MCs in the
presence or absence of B. burgdorferi (s.s.) 297. Tick SGE
induces mast cell degranulation, but MC-degranulation
induced by tick SGE is reduced in the presence of Borrelia
(Fig. 3a). Moreover, tick SGE significantly inhibits the IL-6
(t-test: t(4) = 7.03, P = 0.002 for mRNA, t-test: t(5) = 9.74,
P = 0.0002 for protein) and MCP-1 (t-test: t(5) = 2.93,
P = 0.032) expression induced by Borrelia-activated MC
(Fig. 3b–d).
Mast cells do not impact B. burgdorferi (s.s.) 297
amplification and dissemination during primary infection
We have seen that B. burgdorferi (s.s.) 297 activates pri-
mary MCs in vitro in an L-OspC-independent way.
However, the role of MC in vivo during B. burgdorferi
(s.s.) 297 infection has never been investigated so far. To
Fig. 1 Mouse mast cell response to Borrelia and OspC. Primary MCs from C57BL/6 mice were activated with different concentrations of Borrelia burgdorferi
(s.s.) 297 strain (MOI 10:1 or 50:1) or Lipidated-OspC (L-OspC: 10 or 50 ng/ml). After 2 h, the level of degranulation was evaluated by measuring β-
hexasominidase release and percentage degranulation was calculated according to the negative control (a). After 24 h, supernatants were collected to
measure IL-6 concentration by ELISA (b). After 6 h, RNAs were collected to measure IL-6 and MCP-1 mRNA expression (c, d). *P < 0.05; ***P < 0.001
Bernard et al. Parasites & Vectors  (2017) 10:313 Page 4 of 9
Fig. 2 Mouse mast cell response to Borrelia OspC-KO. Primary MCs from C57BL/6 mice were activated with medium (Ø) Borrelia burgdorferi (s.s.) (Bb)
297 (Wt), Bb OspC-KO (OspC-KO) or Bb OspC-complemented strains (OspC-Compl.) (MOI 50:1). After 24 h, supernatants were collected to measure IL-6
concentration by ELISA (a). After 6 h RNAs were collected to measure IL-6 and MCP-1 mRNA expression (b, c). *P < 0.05; **P < 0.01; ***P < 0.001
Fig. 3 Impact of tick saliva on mouse mast cell inflammatory response. Primary MCs from C57BL/6 mice were activated with Borrelia burgdorferi
(s.s.) 297 strain (MOI 50:1) in the absence (white bars) or presence (black bars) of tick salivary gland extract (SGE: 20 μg/ml). After 2 h, the level of
degranulation was evaluated by measuring β-hexasominidase release and percentage degranulation was calculated (a). After 24 h, supernatants
were collected to measure IL-6 concentration by ELISA (b). After 6 h, RNAs were collected to measure IL-6 and MCP-1 mRNA expression (c, d).
*P < 0.05; **P < 0.01; ***P < 0.001
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explore the impact of MC during mouse infection by B.
burgdorferi (s.s.) 297, we analyzed bacteria multiplication
in the skin as well as its dissemination in wild type
C57BL/6 versus KitWsh−/− mice (Fig. 4, Table 1). No sig-
nificant difference was observed in terms of bacteria
multiplication in the skin (ANOVA: F(3, 65) = 0.43,
P = 0.72) (Fig. 4). Borrelia dissemination in mice was
not significantly altered in the absence of mast cells, al-
though one KitWsh−/− mouse showed a positive Borrelia
count at day 15 at the ear while all C57BL/6 mice were
negative (Table 1).
Discussion
The skin is one of the first defense organ that pathogens
have to cross to infect the host in the context of
arthropod-borne diseases [5, 34]. Some bacteria, para-
sites and viruses have evolved to use vectors, such as
ticks and mosquitoes, to bypass this physical barrier.
However, once pathogens have been injected into the
skin by vectors, they have to face a biological barrier
made of skin cells and inflammatory molecules. In Lyme
borreliosis, bacteria remain in the skin for days, first
interacting with resident skin cells and immune cells be-
fore disseminating to target organs (joints, ear, heart,
nervous system). Those cells, including keratinocytes, fi-
broblasts, macrophages, dendritic cells, neutrophils, NK
cells, T and B cells secrete inflammatory molecules such
as antimicrobial peptides, cytokines, chemokines, adhe-
sins and reactive oxygen species to stop the infection
[31–42]. MCs are present in the skin in large quantity.
Early studies on the interaction of MCs with B. burgdor-
feri (s.s.) have been done with rat peritoneal MCs and
murine MC/9 MCs line [25, 26], and, to our knowledge,
the ability of mice primary MCs to interact with Borrelia
has not been investigated to date. Cell lines are widely
used in many types of cancer research as well as in
immunological or metabolism studies. However, their
behavior may differ from primary cells [42]. We thus
decided to explore the ability of mouse primary MCs to
respond to B. burgdorferi (s.s.) 297. Primary MCs express
IL-6 and MCP-1 in response to Borrelia. The expression
of these two genes has been shown in mouse skin in re-
sponse to Borrelia infection [3]. Moreover, IL-6 has been
essentially associated with late symptoms such as
arthritis and neuroborreliosis [43, 44], but also with ery-
thema migrans and with late skin symptoms [45]. IL-6 is
of importance since this cytokine has a crucial role dur-
ing the transition from innate to acquired immunity. Its
potential release in the skin by resident MCs might par-
ticipate in early cell attraction such as neutrophils [46].
MCs also express IL-6 and MCP-1 in response to L-
OspC. OspC is an essential lipoprotein when it enters
the host skin and is already expressed by the bacteria
during the tick blood meal [47]. If OspC role is not clear,
its involvement in the early course of the infection has
been demonstrated [28] and recent data [48] tend to in-
dicate that it has an antiphagocytic activity. Also, OspC
exhibits a protective role against the innate immune sys-
tem [49]. A previous study has determined the inability
of the lipoprotein OspA to activate TNF-α secretion by
MC/9 MCs [25]. OspA is mainly expressed in ticks and
is downregulated during the early transmission to the
Fig. 4 Role of mast cells upon mouse infection by Borrelia. C57BL/6
(white bars) or KitWsh −/− (black bars) mice were infected intradermally
with Borrelia burgdorferi (s.s.) (Bb) 297 strain (103 bacteria/100 μl) by
syringe inoculation. The relative quantification of Bb, presented as
copies of flab transcript per 104 copies of gapdh transcripts, at the site
of inoculation (skin of the mouse back) was measured by qPCR at
different time points (d = day) after the infection. Results of three
separate experiments are presented. *P < 0.05
Table 1 Impact of mast cell deficiency on B. burgdorferi (s.s.)
297 dissemination
Day/ Organ Joints (%)a Heart (%)a Ear (%)a
C57BL/6 (10 weeks)
Day 3 (n = 8) 0 0 0
Day 5 (n = 8) 0 0 0
Day 7 (n = 5) 60 0 0
Day 15 (n = 8) 75 0 0
KitWsh −/− (10 weeks)
Day 3 (n = 7) 0 0 0
Day 5 (n = 10) 10 0 0
Day 7 (n = 12) 50 0 0
Day 15 (n = 10) 90 0 10
Wild type or KitWsh −/− mice were infected intradermally with Borrelia
burgdorferi 297 strain (103 bacteria/100 μl) by syringe inoculation. The
dissemination of Borrelia was determined by in vitro culture and by qPCR
performed on the different distant organs: the joint, the heart and the ear
aThe percentage of positive samples to Borrelia is calculated according to 5
mice minimum per group
Abbreviations: n number of mice per group, day day of infection
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vertebrate hosts [50]. MC activation thus differs between
Borrelia lipoproteins, since the lipidated OspC protein
induced a strong degranulation, but not OspA nor the
unlipidated OspC protein. Moreover, although lipopro-
teins are the major molecules on the surface of the bac-
teria [51], whole Borrelia parasites do not induce mast
cell degranulation of mast cell line [25] and primary
mast cells. Altogether, we can assume that the lipid part
of OspC, anchored and hidden in the bacteria mem-
branes, induces degranulation. Moreover, the amount of
OspC present on the whole bacteria might be not suffi-
cient to induce degranulation compared to the purified
lipoprotein. Globally, the differences might be due to the
cell state (line versus primary) or molecules studied
(TNF-α versus IL-6/MCP-1). However, OspC is not
sufficient and the only lipoprotein involved in MC acti-
vation in the context of the whole bacteria since an
OspC-deficient strain of B. burgdorferi (s.s.) 297 still ac-
tivates MC similarly to the wild type. Borrelia is recog-
nized by different Toll like receptors (TLRs) [52] and
the absence of OspC might be counteracted by other
Borrelia surface antigens like flagellin interacting with
TLR5. It might also be balanced by the presence of other
lipoproteins or even other ligands since B. burgdorferi
(s.s.) 297 activate immune cells through many PRRs [53].
Our experiment also suggests that in contrast to lipo-
polysaccharides or lipotechoic acid [54], Borrelia and its
lipoprotein are not able to induce cathelicidin expression
by MCs. This might be due to the different TLRs those
ligands are associated with.
During Borrelia transmission to the vertebrate host,
bacteria are injected into the skin with tick saliva. We
have shown here that tick salivary gland extract signifi-
cantly but not completely inhibits IL-6 and MCP-1 ex-
pression by MCs. The ability of tick saliva to decrease
inflammatory cytokine secretion was already observed
on other cell types such as keratinocytes, dendritic cells
and T cells. To determine whether the inhibition is due
to a direct binding of salivary molecules to the bacteria,
or to the cells, requires further studies, given the com-
plexity of the tick saliva [11]. The impact of tick saliva
on MCs during B. burgdorferi (s.s.) 297 transmission has
not been investigated before. However, the involvement
of MCs during non-infectious tick bite was analyzed in
several studies. Histological analyses of BALB/c mice
skin after Dermacentor variabilis tick bite, revealed an
increased number of MCs especially after second or
third tick infestation [55, 56]. Similar observations were
made with Ixodes ricinus infested rabbits [57]. However,
the role of MCs in acquired tick resistance seems to de-
pend on the tick species involved [56, 58]. Although tick
saliva induces MC degranulation, it is also known to
contain molecules able to counteract granules-contained
mediators after their release. For instance, tick saliva
contains lipocalins which can bind histamine to inhibit
their functions, especially itching feelings [59]. Interest-
ingly, we have seen that B. burgdorferi inhibits in part
the MCs degranulation induced by tick saliva. This
mechanism might help the bacteria to reduce inflam-
mation. Similar observation was made with another
bacteria, a non-pathogenic Escherichia coli strain, able
to inhibit anti-2,4 dinitrophenol IgE sensitized MCs
degranulation [60]. However, it remains to be ex-
plored if the B. burdorferi mediated inhibition of the
degranulation induced by tick saliva is specific to this
spirochete or not.
Borrelia burgdorferi (s.s.) multiplies first in the skin of
C3H/HeN mouse before to efficiently disseminate to tar-
get organs such as the heart, the brain or the joints [33].
We thus explored the impact of MCs deficiency on the
multiplication and the dissemination of the bacteria
using a MC deficient murine model. This model already
revealed an important role of MCs during Leishmania
infection, a vector-borne disease transmitted by Phlebo-
tomus sand flies [61, 62]. Since in Lyme borreliosis, the
role of MCs has never been investigated in vivo, we in-
fected MC deficient mice with B. burgdorferi (s.s.) 297
and compared to wild type mice, C57BL/6. Interestingly,
the absence of MC does not influence bacteria multipli-
cation happening at day 5/7 post infection in mice as
previously described in C3H/HeN mice infected with
Borrelia [3]. It does not alter significantly the bacteria
dissemination ability neither. Despite the MC ability of
this mouse strain to promote in vitro an inflammatory
response against Borrelia, in our in vivo model, mast
cells do not control bacterial proliferation during pri-
mary infection and the establishment of the primary in-
fection. It is also known that the genetic background of
MCs deficient mice (C57BL/6) is not optimal to study B.
burgdorferi (s.s.) 297 infection since it shows some resist-
ance [63]. MCs might have a higher impact on more
susceptible mice such as C3H/HeN mice, but no MC de-
ficient mice are available in this genetic background. In
addition, we had to wait 10 weeks in KitWsh −/− mice to
get a very low level of MCs [64]. This age might also
likely affect the outcome of infection since in C3H/HeN
mice, the infection of mice with Borrelia is usually
performed at 3 weeks of age. As with tick infestation
[55, 56], a role of MCs could occur during secondary of
tertiary infection by B. burgdorferi (s.s.) 297. Moreover,
MC might have a role on long term infection, by stimu-
lating the adaptive system [65].
Conclusions
MCs have been associated to the disease severity in mal-
aria, another vector-borne disease [66]. In Lyme disease,
these cells appear to be of lesser importance against
Borrelia. In our study, we show that MCs do not have a
Bernard et al. Parasites & Vectors  (2017) 10:313 Page 7 of 9
protective role against Borrelia infection in vivo. However,
these cells might be important for repeated infections. In
patients regularly bitten by ticks, a skin inflammatory re-
sponse is clearly described [67, 68] with an IgE antibody
response against tick saliva [69]. The impact of tick saliva
resistance on a subsequent Borrelia infection remains to
be explored in models such as guinea pigs, since mice do
not really develop tick saliva resistance [70].
Additional file
Additional file 1: Figure S1. Mast cell purity analyzed by flow cytometry.
Primary MCs generated by culturing mice bone marrow cells for 4 weeks
with IL-3/SCF were processed for staining with PE-labeled rat anti-mouse
CD 117 and APC-labeled american hamster anti-mouse FcεRI. A FACScalibur
equipped with Flowjo software was used for flow cytometry analysis.
(TIFF 8219 kb)
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